Lista de obras - Tracy L Nero - Dominio Público Uruguay

A dual role for the N-terminal domain of the IL-3 receptor in cell signalling.

artículo científico publicado en 2018

Activity-modulating monoclonal antibodies to the human serine protease HtrA3 provide novel insights into regulating HtrA proteolytic activities.

artículo científico publicado en 2014

Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).

artículo científico publicado en 2004

Aspartate aminotransferase: investigation of the active sites.

artículo científico publicado en 1990

Computer-aided mapping of the beta-adrenoceptor. 1. Explanation for effect of para substitution on blocking activity at the beta-1-adrenoceptor.

artículo científico publicado en 1992

Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling

artículo científico publicado en 2016

Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362.

scientific article published on 19 February 2014

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9.

artículo científico publicado en 2015

Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody

artículo científico publicado en 2014

EPO does not promote interaction between the erythropoietin and beta-common receptors

artículo científico publicado en 2018

Evaluation of the predicted secondary structure of bacteriorhodopsin. Prediction of the bovine rhodopsin secondary structure and its sequence similarity with bacteriorhodopsin

scientific article published on 01 August 1992

Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms

artículo científico publicado en 2020

Molecular studies of alpha-2-adrenoceptor and catecholamine-insensitive imidazoline-receptor binding sites using [3H]-rilmenidine in rat brain and kidney

artículo científico publicado en 1993

Oncogenic protein interfaces: small molecules, big challenges.

artículo científico publicado en 2014

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

artículo científico publicado en 2015

Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA.

artículo científico publicado en 2014

Protein structure and computational drug discovery

scientific article published on 20 September 2018

Repurposing the selective estrogen receptor modulator to suppress gastrointestinal cancer growth

artículo científico publicado en 2019

Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.

artículo científico publicado en 2006

Role of beta-adrenergic receptor subtypes in lipolysis

scientific article published on 01 December 2000

Role of the β Common (βc) Family of Cytokines in Health and Disease

artículo científico publicado en 2017

Small molecule proprotein convertase inhibitors for inhibition of embryo implantation

artículo científico publicado en 2013

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

artículo científico publicado en 2013

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment.

artículo científico publicado en 2017

The 'Q-band' absorption spectra of hematoporphyrin monomer and aggregate in aqueous solution

scientific article published on 01 January 1989

The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities

artículo científico publicado en 2018

The βc receptor family - Structural insights and their functional implications

artículo científico

Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

artículo científico publicado en 2017

Unexpected mechanisms of action for a cytokine receptor-blocking antibody.

artículo científico publicado en 2014

[3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney

scientific article published on 01 October 1998

beta(1)- and beta(2)-Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines

artículo científico publicado en 1999

Lista de obras de Tracy L Nero

A dual role for the N-terminal domain of the IL-3 receptor in cell signalling.

Activity-modulating monoclonal antibodies to the human serine protease HtrA3 provide novel insights into regulating HtrA proteolytic activities.

Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).

Aspartate aminotransferase: investigation of the active sites.

Computer-aided mapping of the beta-adrenoceptor. 1. Explanation for effect of para substitution on blocking activity at the beta-1-adrenoceptor.

Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling

Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362.

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9.

Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody

EPO does not promote interaction between the erythropoietin and beta-common receptors

Evaluation of the predicted secondary structure of bacteriorhodopsin. Prediction of the bovine rhodopsin secondary structure and its sequence similarity with bacteriorhodopsin

Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms

Molecular studies of alpha-2-adrenoceptor and catecholamine-insensitive imidazoline-receptor binding sites using [3H]-rilmenidine in rat brain and kidney

Oncogenic protein interfaces: small molecules, big challenges.

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA.

Protein structure and computational drug discovery

Repurposing the selective estrogen receptor modulator to suppress gastrointestinal cancer growth

Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.

Role of beta-adrenergic receptor subtypes in lipolysis

Role of the β Common (βc) Family of Cytokines in Health and Disease

Small molecule proprotein convertase inhibitors for inhibition of embryo implantation

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription.

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment.

The 'Q-band' absorption spectra of hematoporphyrin monomer and aggregate in aqueous solution

The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities

The βc receptor family - Structural insights and their functional implications

Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites

Unexpected mechanisms of action for a cytokine receptor-blocking antibody.

[3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney

beta(1)- and beta(2)-Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines